Metastatic Cancer refers to any cancer that has spread from its primary location to other organs of the body. Many cancers end up spreading to other organs and metastatic cancers are more difficult to treat and require chemotherapy regimens as localized surgical or radio therapy options are not usually effective.
Clinical Trials (medical research studies) are an in important step in the development of new cancer treatments. There are 113 metastatic cancer clinical trials currently active in the United States. Approximately 210 interventions are being tested in metastatic cancer clinical trials. Of the 113 trials, 25 trials are in Phase I (means very early stage drug testing), 33 trials are in Phase II and 19 clinical trials are in Phase III. Below is a summary of some interventions, clinical trial researchers and investigators, cancer research medical centers/sites.
Metastatic Cancer clinical trials interventions
- Laboratory Biomarker Analysis
- Quality-Of-Life Assessment
- Stereotactic Radiosurgery
- Radiation Therapy
- Oxaliplatin
- Therapeutic Conventional Surgery
- Capecitabine
- Cyclophosphamide
- Questionnaire Administration
- Trastuzumab
- Zoledronic Acid
- Pharmacological Study
Sites/Medical Centers doing Metastatic Cancer Clinical Trials
- Gundersen Lutheran Center for Cancer and Blood
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- University of California, San Diego Cancer Center
- Cancer Centers of Southwest Oklahoma
- Florida International University College of Medicine Practice
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
- Stanford University School of Medicine
- University of California San Diego
- British Columbia Cancer Agency
- University of Chicago
- Gundersen Lutheran Center for Cancer and Blood
Clinical Trial Investigators for Metastatic Cancer
- NCI Referral Office (National Institutes of Health Clinical Center, 9000 Rockville Pike)
- Charles Scoggins, M.D. (University of Louisville)
- Use link at the bottom of the page to see if you qualify for an enrolling site (see list). If you still have questions: ()
- Efrat Dotan, MD (Fox Chase Cancer Center)
- Clinical Trials Office - Knight Cancer Institute at Oregon Hea (Knight Cancer Institute at Oregon Health and Science University)
- Philip D. Bonomi (Rush University Medical Center)
- Stephanie E Weiss, MD (Dana-Farber Cancer Institute)
- Nishita Kothary, MD (Stanford Hospital and Clinics)
- Clinical Trials Office - Kosair Children's Hospital (Kosair Children's Hospital)
- David Peereboom, MD (Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center)
- Clinical Trials Office - Gundersen Lutheran Cancer Center (Gundersen Lutheran Center for Cancer and Blood)
- Site Reference ID/Investigator# 6653 (Site Reference ID/Investigator# 6653)
List of Clinical Trials for Metastatic Cancer
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
- High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
- Phase II Gemzar Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA
- A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
If you are interested in participating in a clinical trial of metastatic cancer, you can find trials near you.
Related posts: